{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:57:27Z","timestamp":1786136247270,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006578","name":"Chi Mei Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006578","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jmii.2026.07.007","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T06:16:44Z","timestamp":1785133004000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synergistic activity of mitomycin C in combination with ciprofloxacin against severe Vibrio vulnificus infection"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0804-6153","authenticated-orcid":false,"given":"Cheng-Fa","family":"Yeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6334-2388","authenticated-orcid":false,"given":"Chih-Cheng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping\u2010Yu","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6574-236X","authenticated-orcid":false,"given":"Jin-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Jen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0863-203X","authenticated-orcid":false,"given":"Wen-Pin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jmii.2026.07.007_bib1","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.tim.2022.05.009","article-title":"Complex regulatory networks of virulence factors in Vibrio vulnificus","volume":"30","author":"Choi","year":"2022","journal-title":"Trends Microbiol"},{"issue":"6","key":"10.1016\/j.jmii.2026.07.007_bib2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/cid\/ciq251","article-title":"Vibrio vulnificus oysters: pearls and perils","volume":"52","author":"Daniels","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jmii.2026.07.007_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03674-23","article-title":"Tracking Vibrio: population dynamics and ecology of Vibrio parahaemolyticus and V. vulnificus in an Alabama estuary","volume":"12","author":"Morrison","year":"2024","journal-title":"Microbiol Spectr"},{"issue":"6","key":"10.1016\/j.jmii.2026.07.007_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJM198502073120604","article-title":"Cholera and other vibrioses in the United States","volume":"312","author":"Morris","year":"1985","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jmii.2026.07.007_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13017-022-00433-z","article-title":"In-hospital mortality associated with necrotizing soft tissue infection due to Vibrio vulnificus: a matched-pair cohort study","volume":"17","author":"Chang","year":"2022","journal-title":"World J Emerg Surg"},{"issue":"2","key":"10.1016\/j.jmii.2026.07.007_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jmii.2024.12.005","article-title":"Synergistic effect of repurposed mitomycin C in combination with antibiotics against Aeromonas infection: in vitro and in vivo studies","volume":"58","author":"Yeh","year":"2025","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2026.07.007_bib7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non\u2013 muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.jmii.2026.07.007_bib8","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1021\/tx3002065","article-title":"A new mechanism of action for the anticancer drug mitomycin C: mechanism-based inhibition of thioredoxin reductase","volume":"25","author":"Paz","year":"2012","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.jmii.2026.07.007_bib9","series-title":"Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria","year":"2015"},{"key":"10.1016\/j.jmii.2026.07.007_bib11","series-title":"Performance standards for antimicrobial susceptibility testing; approved standard. 33th informational supplement. CLSI document M100-S33","year":"2023"},{"issue":"4","key":"10.1016\/j.jmii.2026.07.007_bib12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/antibiotics8040184","article-title":"The potential role of sulbactam and cephalosporins plus Daptomycin against Daptomycin-Nonsusceptible VISA and H-VISA isolates: an In Vitro Study","volume":"8","author":"Lai","year":"2019","journal-title":"Antibiotics (Basel)"},{"issue":"2","key":"10.1016\/j.jmii.2026.07.007_bib13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jmii.2016.03.003","article-title":"Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: combination of tigecycline or doxycycline and gentamicin or amikacin","volume":"52","author":"Tang","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"issue":"10","key":"10.1016\/j.jmii.2026.07.007_bib14","doi-asserted-by":"crossref","first-page":"e00310","DOI":"10.1128\/AAC.00310-19","article-title":"In Vitro synergy and In Vivo activity of tigecycline-ciprofloxacin combination therapy against Vibrio vulnificus sepsis","volume":"63","author":"Kim","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jmii.2026.07.007_bib15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jmii.2016.04.009","article-title":"In vitro and in vivo antibacterial activity of tigecycline against Vibrio vulnificus","volume":"51","author":"Tang","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"issue":"6","key":"10.1016\/j.jmii.2026.07.007_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00778-21","article-title":"Identification of multiple low-level resistance determinants and coselection of motility impairment upon Sub-MIC ceftriaxone exposure in Escherichia coli","volume":"6","author":"Ching","year":"2021","journal-title":"mSphere"},{"key":"10.1016\/j.jmii.2026.07.007_bib17","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1177\/0192623310386499","article-title":"Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system","volume":"38","author":"Thoolen","year":"2010","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.jmii.2026.07.007_bib18","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/jac\/dkr476","article-title":"Antibiotic therapy for necrotizing fasciitis caused by Vibrio vulnificus: retrospective analysis of an 8 year period","volume":"67","author":"Chen","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.jmii.2026.07.007_bib19","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1128\/AAC.46.11.3580-3584.2002","article-title":"In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnificus","volume":"46","author":"Tang","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.jmii.2026.07.007_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007478","article-title":"Outcomes of third-generation cephalosporin plus ciprofloxacin or doxycycline therapy in patients with Vibrio vulnificus septicemia: a propensity score-matched analysis","volume":"13","author":"Kim","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.jmii.2026.07.007_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.VE-0001-2014","article-title":"The biology of Vibrio vulnificus","volume":"3","author":"Oliver","year":"2015","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jmii.2026.07.007_bib22","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1128\/IAI.01046-08","article-title":"Vibrio vulnificus: disease and pathogenesis","volume":"77","author":"Jones","year":"2009","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.jmii.2026.07.007_bib23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1186\/s12879-021-06518-5","article-title":"Bacteriology and mortality of necrotizing fasciitis in a tertiary coastal hospital with comparing risk indicators of methicillin-resistant Staphylococcus aureus and Vibrio vulnificus infections: a prospective study","volume":"21","author":"Tsai","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.jmii.2026.07.007_bib24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11739-018-1973-0","article-title":"Risk factors associated with bacteremia correlated with mortality in patients with acute bacterial skin and skin structure infection","volume":"14","author":"Chang","year":"2019","journal-title":"Intern Emerg Med"},{"issue":"11","key":"10.1016\/j.jmii.2026.07.007_bib25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2334-11-5","article-title":"Prognostic factors and monomicrobial necrotizing fasciitis: gram-positive versus gram-negative pathogens","volume":"5","author":"Lee","year":"2011","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.jmii.2026.07.007_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13017-021-00373-0","article-title":"Utility of modified laboratory risk indicator for necrotizing fasciitis (MLRINEC) score in distinguishing necrotizing from non-necrotizing soft tissue infections","volume":"16","author":"Wu","year":"2021","journal-title":"World J Emerg Surg"},{"issue":"2","key":"10.1016\/j.jmii.2026.07.007_bib27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijid.2008.04.015","article-title":"Necrotizing fasciitis in southeast Taiwan: clinical features, microbiology, and prognosis","volume":"13","author":"Bair","year":"2009","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jmii.2026.07.007_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.01556","article-title":"Repurposed antimicrobial combination therapy: tobramycin-ciprofloxacin hybrid augments activity of the anticancer drug mitomycin C against multidrug-resistant gram-negative bacteria","volume":"10","author":"Domalaon","year":"2019","journal-title":"Front Microbiol"},{"issue":"9","key":"10.1016\/j.jmii.2026.07.007_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00900-21","article-title":"Enhanced antibacterial activity of repurposed Mitomycin C and Imipenem in combination with the lytic phage vB_KpnM-VAC13 against clinical isolates of Klebsiella pneumoniae","volume":"65","author":"Pacios","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.jmii.2026.07.007_bib30","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.3390\/pharmaceutics14081749","article-title":"Fluoroquinolones hybrid molecules as promising antibacterial agents in the fight against antibacterial resistance","volume":"14","author":"Lungu","year":"2022","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.jmii.2026.07.007_bib31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/antibiotics13020177","article-title":"Repurposing mitomycin C in combination with pentamidine or gentamicin to treat infections with multi-drug-resistant (MDR) Pseudomonas aeruginosa","volume":"13","author":"Svedholm","year":"2024","journal-title":"Antibiotics (Basel)"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118226000939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118226000939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:36:34Z","timestamp":1786134994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118226000939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"alternative-id":["S1684118226000939"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2026.07.007","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic activity of mitomycin C in combination with ciprofloxacin against severe Vibrio vulnificus infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2026.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}